ロード中...
995. A quality improvement initiative to increase penicillin allergy clarification and decrease aztreonam usage
BACKGROUND: Penicillin (PCN) allergy is a serious adverse reaction that prevents the use of first-line therapy. 10% of the population reports a PCN allergy; however, less than 1% is truly allergic. Elimination of false allergies significantly impacts patient’s lives and decreases antimicrobial resis...
保存先:
| 出版年: | Open Forum Infect Dis |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811020/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.859 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|